---
run_id: halo-evidence-vs-diagnosis-validation-v12-famous-sources-supplied-01
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: famous_sources_supplied
run_number: 1
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 102
prompt_source: condition packet (famous_sources_supplied) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: a name-level list of famous source titles and authors, then the frozen Advisor prompt; no benefits cases, summaries, source cards, or tension card - see run-packet.md
source_packet_sha256: fbda9621700ea5a031af698b8700a95ac925370d84a60c86c1d7bce543e8cc3b
condition_packet_sha256: fbda9621700ea5a031af698b8700a95ac925370d84a60c86c1d7bce543e8cc3b
output_file: model-outputs/famous_sources_supplied.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - famous_sources_supplied (run 01)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `famous_sources_supplied`, run 1 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 102, on the frozen condition packet.

## Output

**Recommendation:** Run the **Case Evidence Review**.

**Why:** Your current success is "entangled," meaning your lagging indicators (expansion bookings, shortened sales cycles) are likely being driven by financial incentives (bundle pricing) and sales narratives (roadmap pitches) rather than actual product value. The usage data is equally deceptive: high frequency from managers doesn't equal utility for the front-line analysts who actually execute the workflow.

The Case Evidence Review is the only option that targets the "Jobs-to-be-Done" (as explored in *Competing Against Luck*). By auditing whether suggestions were accepted, overridden, or impossible to explain, you move past vanity metrics (usage %) and sales signals to determine if PlanPilot is solving a core pain point or merely providing a draft that analysts must manually fix. If the product cannot be explained to reviewers (especially in the public sector), you have a fundamental value-proposition gap that no amount of "enablement" or "adoption sprints" will fix.

**The strongest reason against it:** This approach is slow and qualitative. It provides a snapshot of past behavior rather than a real-time validation of future growth. While you are auditing files, the board may perceive a lack of "momentum" compared to scaling broadly or running a high-velocity "Adoption Quality Sprint." It risks discovering that the product is fundamentally flawed just as you are locking in next year's budget, potentially forcing a painful pivot.

**Observable evidence that would change my mind:** If the "Demand Cleanroom" results were to show that expansion bookings and renewal speed remained high even without bundle pricing and roadmap pitches, it would prove that the market perceives value regardless of the internal workflow friction. In that case, the problem is a minor usability issue rather than a core value failure, and I would shift the recommendation to "Scale PlanPilot Broadly."
